首页 Zoetis(usZTS)-基本信息

Zoetis(usZTS)-基本信息

日报更新时间:04-20 10:53

周报更新时间:04-18 04:06

行情信息

今开价:169.58

最高价:171.16

成交量:682173.0

昨收价:168.74

最低价:168.88

最新价:170.43

行情图标
概要信息

英文名称:Zoetis


行业:医疗


简介:硕腾公司于2012年7月在美国特拉华州成立,是全球领先的最大的动物保健药和疫苗公司之一


电话:1-973-8227000


最新量化综合结论
百科信息
  • 相关网站
  • 百科
  • 员工交易记录
  • 持股信息
  • 领导人信息

硕腾公司是世界上最大的宠物和家畜用药品和疫苗厂商,是世界最大的药品制造商辉瑞公司的上市子公司,辉瑞公司占83%的股份(已出售大部分),硕腾公司在全球70个国家运营,最近扩展到东南亚和中国一带。Zoetis Inc.从事家畜与宠物的动物保健药品与疫苗的开发、制造与销售,Zoetis业务经营以区域分为四个部门,分别为美国、欧洲/非洲/中东、加拿大/拉美,亚洲/太平洋。Zoetis 提供的产品包括疫苗、杀寄生虫药、抗感染、加药饲料添加剂及其他药剂,用于家畜与宠物,其直接竞争对手包括默克、赛诺菲、美国礼来等大型制药公司旗下的动物保健部门。硕腾公司Zoetis(ZTS)历史百科: 在20世纪50年代,辉瑞开始研究包括土霉素在内的多种药物。辉瑞产品的化学工程师John McKeen发现其对家畜有效。1952年,辉瑞公司农业事业部(Pfizer Agriculture Division)成立,在印第安纳州特雷霍特开设了732英亩的研发基地Vigo。 1952年,辉瑞农业部门(Pfizer Agriculture Division)成立,是为硕腾公司Zoetis Inc.前身; 1955年,Pfizer Agriculture Division收购葛兰素史克(GlaxoSmithKline)的诺登实验室(Norden Laboratories); 1988年,辉瑞农业部门更名为辉瑞动物健康(Pfizer Animal Health); 1995年,对葛兰素史克公司的诺登实验室(Norden Laboratories)的收购使辉瑞动保部门扩展到包括家养宠物在内的小动物护理领域; 2003年,第2个研发中心在密歇根州卡拉马祖成立。 2003年,辉瑞以60亿美元的股票期权收购法玛西亚公司(Pharmacia Corporation); 2007-2011年,Pfizer Animal Health先后收购Embrex Inc、Catapult Genetics、Bovigen、Wyeth、Fort Dodge Animal Health、Vetnex Animal Health Ltd、Synbiotics Corporation、Microtek、King Pharmaceuticals、Alpharma等公司; 2012年8月13日,辉瑞将动物保健业务(Pfizer Animal Health)分拆独立成一家公司——Zoetis Inc.; 2013年2月1日,硕腾公司(Zoetis Inc.)IPO,发行价26美元,融资22亿美元; 2013年5月22日,辉瑞公司计划出售其在硕腾公司的多数股权,股东将有权选择将他们的辉瑞股票置换成硕腾股票,出售硕腾的计划与辉瑞公司最近清退其它非医药子公司的决定相一致,这些决定的目的是努力节省成本、筹集资金并还清债务。JPMorgan Chase、Bank of America Merrill Lynch、Goldman Sachs & Co.、Morgan Stanley为主承销商; 2014年11月,Bill Ackman公布Pershing Square Capital Management已买进Zoetis公司8.5%股权,约4180万股; 2014年11月17日,硕腾公司宣布将以2.55亿美金收购雅培实验室Abbott Laboratories的宠物药品组合; 2015年11月,Zoetis Inc.宣布以7.65亿美金收购水产品疾病治疗药物公司——Pharamaq; 2017年7月31日,Zoetis 以8500万美元完成收购 Nexvet Biopharma。 2018年5月16日,Zoetis宣布以20亿美元收购兽医诊断公司Abaxis。硕腾公司Zoetis(ZTS)旗下产品包括: Apoquel Bovi-Shield Gold Cerenia Convenia Dectomax Draxxin Excede Excenel Histostat Inovocox Mycitracin Palladia Pirsue A180 Revolution Pet Medicine Rimadyl Simplicef Slentrol Solitude IGR Spectramast Stellamune Stronghold Synulox

交易日期 交易人 职位 类型 交易份额 价格
2019-06-12 Reed Willie M Director Sell 1900 110.58
2019-05-09 Lagano Roxanne Officer Buy 29453 --
2019-05-09 Lagano Roxanne Officer Sell 29453 101.65
2019-02-13 Lewis (Clinton A Jr) Officer Sell 6125 91.96
2019-02-13 Lewis (Clinton A Jr) Officer Buy 3567 --
2018-08-13 Alaix (Juan Ramon) Chief Executive Officer Sell 135000 91.55
2018-08-06 Trawicki (Roman) Officer Sell 8266 92.53
2018-08-06 Trawicki (Roman) Officer Buy 4688 --
2018-03-08 Trawicki (Roman) Officer Sell 8568 83.10
2018-03-08 Trawicki (Roman) Officer Buy 8568 --
2018-02-26 Khosla (Sanjay) Director Sell 1203 81.67
2018-02-26 Khosla (Sanjay) Director Buy 3771 --

机构持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
MFS Investment Management KK 7801894 1.63% 109647 1.43% 2019-03-31
BlackRock Fund Advisors 12203473 2.55% -1210365 -9.02% 2019-07-31
Vanguard Investments Australia Ltd 13360891 2.79% 62570 0.47% 2019-07-31
Morgan Stanley - Brokerage Accounts 13785853 2.88% 127988 0.94% 2019-03-31
AllianceBernstein L.P. 14987889 3.13% 1441288 10.64% 2019-03-31
State Farm Mutual Automobile Ins Co 19124444 4.00% -- -- 2019-03-31
State Street Corporation 20014594 4.18% 803471 4.18% 2019-03-31
Vanguard Group Inc 36419410 7.61% 48286 0.13% 2019-03-31
BlackRock Inc 37486408 7.83% 795558 2.17% 2019-03-31
Polen Capital 10102190 2.11% 548623 5.74% 2019-03-31
Capital Research and Management Company 9956900 2.08% 1610733 19.30% 2019-07-31
Morgan Stanley Investment Management Ltd 8930182 1.87% 379113 4.43% 2019-03-31
Massachusetts Financial Services Company 7801894 1.63% 109647 1.43% 2019-03-31
State Street Global Advisors 7857921 1.64% 12772 0.16% 2019-07-31
Fidelity Management and Research Company 8127077 1.70% 882638 12.18% 2019-03-31
FMR Inc 8127931 1.70% 882183 12.18% 2019-03-31
Fidelity Management & Research Company 8234648 1.72% -928118 -10.13% 2019-07-31
Capital World Investors 8700758 1.82% 1420895 19.52% 2019-03-31
ClearBridge Advisors, LLC 8703622 1.82% 15265 0.18% 2019-03-31
Bank of America Corporation 8794828 1.84% 546838 6.63% 2019-03-31
BlackRock Asset Management Canada Ltd 14936063 3.12% 16246 0.11% 2019-05-31
Geode Capital Management, LLC 12455952 2.60% 7013064 128.85% 2018-12-31
Marshall Wace North America LP 8404482 1.76% 5236402 165.29% 2018-09-30
Brown Advisory Holdings Inc 6483385 1.35% -112593 -1.71% 2018-09-30
TIAA-CREF Investment Management LLC 12880378 2.69% 5974221 86.51% 2018-09-30
Brown Investment Advisory Incorporated 6483010 1.35% -112593 -1.71% 2018-09-30
Goldman Sachs Group Inc 6101066 1.27% -779631 -11.33% 2018-09-30
BlackRock Institutional Trust Company NA 13278224 2.76% -1945283 -12.78% 2018-06-30
State Street Corp 18470179 3.83% -510333 -2.69% 2018-06-30
AllianceBernstein LP 13378544 2.77% -114751 -0.85% 2018-06-30
Brown Brothers Harriman & Co 6757672 1.39% -1323720 -16.38% 2018-03-31
Winslow Capital Management, LLC 5781112 1.20% 2780535 92.67% 2018-06-30
Northern Trust Investments N A 5991814 1.24% 43287 0.73% 2018-06-30
State Street Global Advisors (Aus) Ltd 5597959 1.16% 130695 2.39% 2018-09-12
Waddell & Reed Investment Management Co 5596982 1.16% -611058 -9.84% 2018-06-30
HHG PLC 5410040 1.12% 985586 22.28% 2018-06-30
T. Rowe Price Associates, Inc. 5116408 1.06% -4832383 -48.57% 2018-06-30
Lazard Asset Management LLC 4618961 0.95% 54943 1.20% 2018-03-31
American Century Inv Mgt Inc 5213916 1.08% -331943 -5.99% 2018-03-31
Cantillon Capital Management LLC 5009721 1.03% -347457 -6.49% 2017-12-31
DSM Capital Partners LLC 4020930 0.83% -524459 -11.54% 2018-03-31
Independent Franchise Partners LLP 6495581 1.34% -180109 -2.70% 2017-12-31
ING Investment Management LLC 5220481 1.07% -195155 -3.60% 2017-09-30
Managed Account Advisors LLC 5626393 1.15% 2008226 55.50% 2017-09-30
Massachusetts Financial Services Co 7291975 1.50% -71292 -0.97% 2017-10-31
Morgan Stanley Investment Management Inc 13553803 2.74% -1731970 -11.33% 2016-09-30
Marshall Wace Asset Management Ltd 12647653 2.55% 3487675 38.08% 2016-09-30
Principal Global Investors, LLC 10016876 2.02% 126708 1.28% 2016-09-30
Janus Capital Management LLC 5061003 1.02% 1263483 33.27% 2016-09-30
The Vanguard Group 27373108 2.00% 1261626548 -- 1999-11-30
BlackRock, Inc. 27553426 2.00% 1269937404 0.10% 1999-11-30
Pershing Square Capital Management, L.P. 41823145 2.00% 1927628753 0.10% 1999-11-30
共同基金持股
持有者 持有份额 持股比例 份额变化 变化率 报告日期
American Funds Growth Fund of Amer 2000000 0.42% 1200000 150.00% 2019-06-30
Vanguard 500 Index Fund 9419359 1.97% 93886 1.01% 2019-06-30
American Funds New Perspective Fund 5525000 1.15% -- -- 2019-06-30
SPDR 5334810 1.11% 4879 0.09% 2019-07-31
Vanguard Institutional Index Fund 4469386 0.93% -34833 -0.77% 2019-06-30
MS INVF Global Brands Fund 4125874 0.86% 24029 0.59% 2019-03-31
iShares Core S&P 500 ETF 3517142 0.73% -1734 -0.05% 2019-07-30
MFS Growth Fund 3466985 0.72% 22008 0.64% 2019-06-30
Vanguard Growth Index Fund 3420281 0.71% 112228 3.39% 2019-06-30
Fidelity 3304764 0.69% 56716 1.75% 2019-06-30
CREF Growth Account 3160744 0.66% -266301 -7.77% 2019-05-31
ClearBridge Large Cap Growth Fund 3048996 0.64% 137045 4.71% 2019-06-30
AB Large Cap Growth Fund 2917778 0.61% 24890 0.86% 2019-06-30
Health Care Select Sector SPDR 2409813 0.50% 4480 0.19% 2019-07-31
Janus Henderson Forty Fund 2287377 0.48% -- -- 2019-06-30
Janus Concentrated Growth Tr 2287377 0.48% -- -- 2019-06-30
MainStay Large Cap Growth Fund 2135040 0.45% -39700 -1.83% 2019-05-31
State Street S&P 500 Index Fund 2058612 0.43% 12200 0.60% 2019-06-30
Vanguard Total Stock Market Index Fund 13170846 2.75% 62571 0.48% 2019-06-30
MS INVF US Advantage Fund 1956758 0.41% -199572 -9.26% 2019-03-31
iShares Core MSCI AllCntry Wld exCan ETF 3503433 0.73% 1148 0.03% 2019-05-23
iShares MSCI World ETF 3503433 0.73% 1148 0.03% 2019-05-23
iShares Core S&P 500 ETF (CAD-Hedged) 3516922 0.73% 3157 0.09% 2019-05-30
iShares S&P 500 ETF 3516922 0.73% 3157 0.09% 2019-05-30
iShares Core S&P US Total Market ETF 3516922 0.73% 3157 0.09% 2019-05-30
iShares Core MSCI Kokusai ETF 3516922 0.73% 3157 0.09% 2019-05-30
CREF Stock Account 1919727 0.40% -63426 -3.20% 2019-02-28
Undrly L&G Diversified Life 2073742 0.43% 2073742 -- 2018-09-30
Undrly L&G Pen PMC Diversified 2073742 0.43% 2073742 -- 2018-09-30
RI CBF AllianceBern Large Cap Gr Por 2867498 0.60% 500040 21.12% 2019-01-31
VA CollegeAmerica New Perspective Fd 5325000 1.11% -- -- 2018-12-31
Vanguard Windsor 1722747 0.36% -213700 -11.04% 2018-12-31
Pioneer Fundamental Growth Fund 1748197 0.37% -- -- 2018-12-31
OH Putnam Fidelity Spartan 500 Index 3599324 0.75% 104143 2.98% 2019-01-31
Principal LargeCap Growth Fund I 1861290 0.39% -59749 -3.11% 2018-12-31
iShares Russell Mid-Cap Growth ETF 1597650 0.33% 1914 0.12% 2018-06-21
MFS 3044230 0.63% 21392 0.71% 2018-09-30
T. Rowe Price Capital Appreciation Fund 3608600 0.75% -313138 -7.98% 2017-12-31
AZ InvestEd Ivy Mid Cap Growth E 1492492 0.31% -105108 -6.58% 2018-06-30
Vanguard Total Stock Mkt Idx 12164264 2.52% 47622 0.39% 2018-07-31
Vanguard 500 Index Inv 8763050 1.82% 12231 0.14% 2018-07-31
VA CollegeAmerica New Perspective 529E 5092000 1.06% 1717000 50.87% 2018-06-30
Vanguard Institutional Index I 4682408 0.97% 6555 0.14% 2018-07-31
Vanguard Growth Index Inv 3406582 0.71% -11122 -0.33% 2018-07-31
CREF Growth R1 3249958 0.67% 15688 0.49% 2018-07-31
Fidelity Spartan 3223120 0.67% 38018 1.19% 2018-07-31
Janus Forty S 2897875 0.60% -- -- 2018-06-30
MFS Growth B 2934348 0.61% 109303 3.87% 2018-07-31
iShares Russell 1000 Growth 1579967 0.32% -1088 -0.07% 2018-09-12
Pioneer Fundamental Growth A 1665603 0.35% 254348 18.02% 2018-06-30
MainStay Large Cap Growth A 1836400 0.38% -12200 -0.66% 2018-07-31
Principal LargeCap Growth I Instl 1944429 0.40% 3169 0.16% 2018-07-31
RI CBF AllianceBern Large Cap Gr Port RZ 2339268 0.49% -14660 -0.62% 2018-07-31
CREF Stock R1 2556750 0.53% 14469 0.57% 2018-07-31
ClearBridge Large Cap Growth A 2718308 0.56% 9810 0.36% 2018-07-31
T. Rowe Price Mid-Cap Value 1593600 0.33% -550500 -25.68% 2018-03-31
iShares Russell Mid-Cap Growth 1597650 0.34% 1914 0.12% 2018-06-21
T. Rowe Price Capital Appreciation 3608600 0.74% -313138 -7.98% 2017-12-31
T. Rowe Price Mid-Cap Growth 2500000 0.51% -500000 -16.67% 2017-12-31
Prudential Jennison Mid Cap Growth A 1713810 0.35% -18258 -1.05% 2017-12-31
T. Rowe Price Growth Stock 3691926 0.75% -964850 -20.72% 2017-09-30
Principal MidCap R2 5824083 1.18% -244905 -4.04% 2016-12-31
BBH Core Select N 2712190 0.54% -- -- 2017-01-31
MFS Massachusetts Investors Gr Stk A 2720074 0.55% -39560 -1.43% 2016-12-31
Strategic Advisers 2591668 0.52% 145595 5.95% 2016-12-31
T. Rowe Price Blue Chip Growth 2398900 0.49% -78000 -3.15% 2016-12-31
Principal MidCap Fund 5160151 1.00% 729465 16.50% 2015-10-31
Vanguard Health Care Fund 4804337 1.00% -311500 -6.10% 2015-09-30
SPDR® S&P 500® ETF Trust 4624109 0.90% -- -- 2015-09-30
SPDR® S&P 500 ETF 4447088 1.00% 33540 0.80% 2015-11-19
BBH Core Select Fund 4088849 0.80% -137950 -3.30% 2015-10-31
Morgan Stanley Inst Mid Cap Growth Port 3057940 0.60% -712672 -18.90% 2015-09-30
MS INVF US Advantage 2720278 0.60% 285759 11.70% 2015-10-31
AZ InvestEd Ivy Mid Cap Growth Fund 2449970 0.50% 335129 15.80% 2015-09-30
Health Care Select Sector SPDR® Fund 2329548 0.50% -11530 -0.50% 2015-11-19
Vanguard Windsor II Fund 7629697 1.50% 1727560 29.30% 2015-09-30

Mike B. McCallister Mike B. McCallister is a businessperson who has been at the head of 6 different companies. He occupies the position of Non-Executive Chairman at Zoetis, Inc., Chairman & Chief Executive Officer at Humana Health Benefit Plan of Louisiana, Inc., Chairman, President & Chief Executive Officer for Humana Wisconsin Health Organization Insurance Corp., Chairman & Chief Executive Officer of Humana Employers Health Plan of Georgia, Inc. and Chairman & Chief Executive Officer of Humana Benefit Plan of Illinois, Inc. Mike B. McCallister is also on the board of 5 other companies. In his past career he held the position of Non-Executive Chairman for Humana, Inc. Mr. McCallister received an undergraduate degree from Louisiana Tech University and an MBA from Pepperdine University.
Louise M. Parent Louise M. Parent is on the board of Zoetis, Inc., Smith College, Fidelity National Information Services, Inc. and Cold Spring Harbor Laboratory, Inc. and Of Counsel at Cleary Gottlieb Steen & Hamilton LLP. She previously occupied the position of Executive Vice President & General Counsel for American Express Co. and Executive Vice President for RiverSource Investments LLC. Ms. Parent received an undergraduate degree from Smith College and a graduate degree from Georgetown University Law Center.
Linda Rhodes Founder of Aratana Therapeutics, Inc. and AlcheraBio LLC, Linda Rhodes is on the board of Zoetis, Inc. and Alliance for Contraception for Cats & Dogs. She previously held the position of Chief Scientific Officer of Aratana Therapeutics, Inc., Partner at AlcheraBio LLC and Director-Production Animal Development Projects at Merial, Inc. Linda Rhodes received a doctorate from Cornell University, an undergraduate degree from Sarah Lawrence College and a doctorate from the University of Pennsylvania School of Veterinary Medicine.
Robert W. Scully Robert W. Scully is on the board of UBS AG and 7 other companies. In his past career Mr. Scully occupied the position of Managing Director & Member-Chairman Office at Morgan Stanley, Managing Director at Scully Brothers & Foss, Managing Director at Lehman Brothers, Inc. and MD, MD-Investment Banking & Capital Markets at Salomon Brothers. He received an undergraduate degree from Princeton University and an MBA from Harvard University.
Kristin C. Peck Kristin C. Peck is on the board of Thomson Reuters Corp. and Reuters Transaction Services Ltd. and Executive Vice President & President-US Operations at Zoetis, Inc. In her past career Ms. Peck occupied the position of Principal at The Boston Consulting Group, Inc. and EVP-Worldwide Business Development & Innovation at Pfizer Inc. She received an undergraduate degree from Georgetown University and an MBA from Columbia Business School.
Andrew Fenton Presently, Andrew Fenton is Chief Digital & Technology Officer, Executive VP at Zoetis, Inc. Mr. Fenton previously held the position of Partner at Ernst & Young Global Ltd. and Partner at Ernst & Young LLP (a subsidiary of Ernst & Young Global Ltd.) and Chief Information Officer & Senior Vice President of Warner Chilcott Plc. He received an undergraduate degree from British Columbia Institute of Technology.
William C. Steere William C. Steere is on the board of Zoetis, Inc. and NYU Elaine A. & Kenneth G. Langone Medical Center and Vice Chairman & President at The New York Botanical Garden. In his past career he held the position of Chairman-Emeritus at Pfizer Inc. He received an undergraduate degree from Stanford University.
Paul M. Bisaro Paul M. Bisaro is a businessperson who has been at the head of 11 different companies. He holds the position of Executive Chairman for Amneal Pharmaceuticals, Inc. He is also on the board of Zoetis, Inc., Anda, Inc. (former President & Director), Columbus School of Law and Zimmer US, Inc. In his past career he was Director at Allergan Plc Executive Chairman of Forest Laboratories, Inc. Chairman, President & Chief Executive Officer of Actavis, Inc. and President & Chief Executive Officer at Warner Chilcott Plc (which are all subsidiaries of Allergan Plc), Associate at Winston & Strawn LLP, Associate for Bishop, Cook, Purcell & Reynolds, Senior Consultant at Arthur Andersen LLP, President, Chief Executive Officer & Director at Impax Laboratories LLC, President for Teva Women's Health, Inc., President, Chief Operating Officer & Director at Barr Pharmaceuticals, Inc., President & Chief Operating Officer for Barr Laboratories, Inc. and Chairman for Association for Accessible Medicines. Mr. Bisaro received an undergraduate degree from the University of Michigan and a graduate degree from The Catholic University of America.
Frank A. D'Amelio Currently, Frank A. D'Amelio holds the position of Chief Financial Officer & EVP-Business Operations at Pfizer Inc. He is also on the board of Humana, Inc., Zoetis, Inc. (former Chairman), Independent College Fund of New Jersey and The Gillen Brewer School. He previously was Principal at AT&T, Inc., Chief Operating Officer & Director at Lucent Technologies, Inc., Chief Administrative Officer & SEVP-Integration at Alcatel-Lucent SAS, Chief Administrative Officer & Senior Executive VP at Nokia of America Corp. and Principal at Bell Laboratories. Frank A. D'Amelio received an undergraduate degree from Saint Peter's University and an MBA from St. John's University.
Sanjay Khosla Presently, Sanjay Khosla is Chief Executive Officer at Bunnik LLC. Mr. Khosla is also on the board of 4c Insights, Inc., Zoetis, Inc. and CarePredict, Inc. and Senior Fellow at Kellogg School of Management. In the past he was President-Developing Markets at Kraft Foods, Inc. (New Jersey), Managing Director at Fonterra Brands Ltd., President at Kraft International Commercial and Senior Vice President-Global Beverages at Unilever United States, Inc. Mr. Khosla received an undergraduate degree from Indian Institute of Technology New Delhi.
Gregory Norden Currently, Gregory Norden holds the position of Managing Director at G9 Capital Group LLC. He is also on the board of 6 other companies. In the past he held the position of Audit Manager at Arthur Andersen LLP, Chief Financial Officer& Executive Vice President at Wyeth Pharmaceuticals LLC, Vice President-Finance at Ayerst Laboratories, Inc. and Chief Financial Officer & Senior Vice President for Wyeth Corp. Mr. Norden received a graduate degree from Long Island University and an undergraduate degree from State University of New York College at Plattsburgh.
John O'Connor Currently, John O'Connor holds the position of Senior VP-Finance & Treasury at Zoetis, Inc. He previously held the position of Research Associate at Morgan Stanley & Co. LLC.
Juan Ram�0�1�0�6n Alaix Presently, Juan Ram�0�1�0�6n Alaix is Chief Executive Officer & Director at Zoetis, Inc. He is also on the board of International Federation for Animal Health (former President & Director). In his past career he occupied the position of President-Spain Market at Pharmacia Spain SA. Mr. Alaix received an undergraduate degree from Universidad Complutense de Madrid.
Heidi C. Chen Heidi C. Chen is Secretary, Executive VP & General Counsel of Zoetis, Inc. She is also on the board of Asian American Legal Defense & Education Fund. In the past she was Associate for Hughes Hubbard & Reed LLP and Assistant General Counsel at Pfizer Inc. Ms. Chen received an undergraduate degree from Yale University and a graduate degree from Cornell Law School.
Heidi C. Chen Heidi C. Chen is Secretary, Executive VP & General Counsel of Zoetis, Inc. She is also on the board of Asian American Legal Defense & Education Fund. In the past she was Associate for Hughes Hubbard & Reed LLP and Assistant General Counsel at Pfizer Inc. Ms. Chen received an undergraduate degree from Yale University and a graduate degree from Cornell Law School.
Catherine Ann Knupp Presently, Catherine Ann Knupp is Executive VP, President-Research & Development at Zoetis, Inc. In her past career she held the position of Vice President-Michigan laboratories at Pfizer Inc. and Vice President at Pfizer Global Research & Development (a subsidiary of Pfizer Inc.) and Vice President-Chemical Manufacturing Controls at Bristol-Myers Squibb Co. She received a doctorate, a graduate degree and an undergraduate degree from the University of Illinois and an undergraduate degree from Western Illinois University.
Roxanne Lagano Currently, Roxanne Lagano is Chief Human Resources Officer & EVP-Communications at Zoetis, Inc. In her past career she occupied the position of Principal at Schulte Roth & Zabel LLP and Manager-Tax Planning at Pfizer Inc. She received an undergraduate degree from Long Island University, a graduate degree from Maurice A. Deane School of Law at Hofstra University and a graduate degree from Hofstra University.
Clinton A. Lewis Clinton A. Lewis is on the board of International Paper Co. and Executive VP & President-International Operations at Zoetis, Inc. and Treasurer at International Federation for Animal Health Europe. He previously was Senior Vice President-Sales for Pfizer Inc., Chairman for Animal Health Institute and Treasurer for Animal Health Europe. He received an undergraduate degree from Fairfield University and an MBA from Fairleigh Dickinson University.
Willie M. Reed Willie M. Reed is President at The American Association of Avian Pathologists, Inc. Dr. Reed is also on the board of Zoetis, Inc. and Chairman-Research Council at American Veterinary Medical Association and Dean at Purdue University. In the past Willie M. Reed was President at American Association of Veterinary Laboratory Diagnosticians and President at Association of American Veterinary Medical College. Dr. Reed received a doctorate from Purdue University and a doctorate from Tuskegee University.
Glenn C. David Currently, Glenn C. David is Chief Financial Officer & Executive Vice President for Zoetis, Inc. In his past career Mr. David occupied the position of Vice President-Finance & US Primary Care at Pfizer Inc. Mr. David received an undergraduate degree from State University of New York at Binghamton and an MBA from New York University.
Katherine H. Walden Currently, Katherine H. Walden is Chief Compliance Officer & Governance Counsel at Zoetis, Inc.
Steven Frank Currently, Steven Frank is Head-Investor Relations of Zoetis, Inc.

量化对比

全部评论 0

  • 暂无评论

阿布量化公众号二维码 abu_quant 扫一扫关注阿布量化

热门推荐